Ireland
--:--IST
Latest
Clinical Trials in Sweden / NCT05339477
Recruiting Observational

The Physical Activity Post Myocardial Infarction SWEDEHEART Prospective Cohort Study

NCT05339477 · tracked via the Priya Life Science Sweden tracker
Phase
Observational
Started
2022-04-26
Last updated
2025-02-11

Condition(s) studied

Myocardial Infarction

Investigational drug(s) / intervention(s)

Accelerometer measurement

Accelerometer measurement: Study personnel will initiate an accelerometer and inform the patient to wear the accelerometer with an elastic belt on their right hip during waking hours for seven consecutive days. Moreover, patients are instructed to register their wear time in an activity diary in paper form. In addition, patients will register their working hours, if relevant. After seven days, patients send back the accelerometer and diary in a pre-paid envelope. The same procedure is repeated at the second follow-up visit at 1 year.

Study summary

The association between objectively measured physical activity intensities (light, moderate and vigorous), sedentary time and clinical outcomes has not been clarified in patients after a myocardial infarction.

The overall objective of the study is to explore associations between accelerometer measured physical activity and clinical outcomes after a myocardial infarction. Moreover, the association between changes in physical activity and outcomes will be assessed.

Eligibility

Sex
ALL
Min age
18 Years
Max age
79 Years
Healthy volunteers
No
Inclusion Criteria: * Signed informed consent * Diagnosis of a type 1 myocardial infarction registered in SWEDEHEART * Age 18-79 years at discharge from hospital * Attending the first visit in the cardiac rehabilitation (CR) registry SEPHIA (2 months after discharge) Exclusion Criteria: * Inability to understand Swedish * Non-ambulatory * Any mental condition that may interfere with the possibility for the patient to comply with the study protocol

Primary outcome measure(s)

Trial sites (35)

FacilityCityRegionStatus
Alingsås lasarett Alingsås Sweden Recruiting
NU-sjukvården Dalslands sjukhus Bäckefors Sweden Recruiting
Bollnäs sjukhus Bollnäs Sweden Recruiting
Höglandssjukhuset Eksjö Eksjö Sweden Recruiting
Lasarettet Enköping Enköping Sweden Recruiting
Gävle sjukhus Gävle Sweden Not Yet Recruiting
Sahlgrenska University Hospital Sahlgrenska Gothenburg Sweden Recruiting
Helsingborgs lasarett Helsingborg Sweden Recruiting
Jönköping Ryhov Hospital Jönköping Sweden Recruiting
Kalix sjukhus Kalix Sweden Recruiting
Länssjukhuset Kalmar Kalmar Sweden Recruiting
Centralsjukhuset Karlstad Karlstad Sweden Recruiting
Kullbergska sjukhuset Katrineholm Sweden Recruiting
Västmanlands sjukhus Köping Köping Sweden Recruiting
Universitetssjukhuset Linköping Linköping Sweden Recruiting
Sunderby sjukhus Luleå Sweden Recruiting
NU-sjukvården Lysekil Lysekil Sweden Recruiting
Skåne Universitetssjukhus Malmö Malmö Sweden Recruiting
Vrinnevisjukhuset Norrköping Sweden Withdrawn
Oskarshamns sjukhus Oskarshamn Sweden Recruiting
Västmanlands sjukhus Sala Sala Sweden Recruiting
Sandvikens sjukhus Sandviken Sweden Recruiting
Capio Närsjukhus Simrishamn Simrishamn Sweden Recruiting
Skaraborgs sjukhus Skövde Skövde Sweden Recruiting
Söderhamns sjukhus Söderhamn Sweden Not Yet Recruiting
Capio St Göran Stockholm Sweden Recruiting
Karolinska University Hospital Solna and Huddinge Stockholm Sweden Recruiting
Södersjukhuset Stockholm Sweden Recruiting
NU-sjukvården Strömstad Strömstad Sweden Recruiting
Norrlands Universitetssjukhus Umeå Umeå Sweden Active Not Recruiting
Akademiska sjukhuset Uppsala Sweden Recruiting
Hallands sjukhus Varberg Varberg Sweden Recruiting
Värnamo sjukhus Värnamo Sweden Recruiting
Västerviks sjukhus Västervik Sweden Recruiting
Visby Lasarett Visby Sweden Not Yet Recruiting

More Sahlgrenska University Hospital trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05339477 on ClinicalTrials.gov ↗ ← All trials in Sweden